PFIE,Profire Energy, Inc. | Energy

Energy

PFIE

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Profire Energy, Inc.PFIE

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

Market Cap

117.35M

Revenue (ttm)

60.02M

Net Income (ttm)

8.97M

Shares Out

46.20M

EPS (ttm)

0.19

PE Ratio

13.36

Forward PE

15.88

Dividend

n/a

Ex-Dividend Date

n/a

Volume

n/a

Open

n/a

Previous Close

2.540

Day's Range

2.540 - 2.540

52-Week Range

1.330 - 2.560

Beta

0.45

Analysts

Hold

Price Target

2.55 (+0.39%)

Earnings Date

Nov 6, 2024

Description >

Profire Energy, Inc., a technology company, provides burner, and combustion management systems and solutions for natural and forced draft applications in the United States and Canada.

It primarily focuses on the upstream, midstream, and downstream transmission segments of the oil and gas industry.

The company also sells and installs its systems in South America, Europe, Africa, the Middle East, and Asia.

Profire Energy, Inc. was founded in 2002 and is based in Lindon, Utah.

Latest News >

Lamar Advertising Expands Buyback Plan to $250 Million, Maintains Dividend

May 26, 2025

04:57 PM EDT, 05/15/2025 (MT Newswires) -- Lamar Advertising ( LAMR ) approved a $150 million increase to its share buyback plan, boosting the total to $250 million. A $150 million buyback was competed under an existing program with $100 million still available, the company said Thursday in a statement. The company maintained its quarterly dividend at $1.55 a share,...

Globus Medical Launching $500 Million Share Buyback Plan

May 26, 2025

04:57 PM EDT, 05/15/2025 (MT Newswires) -- Globus Medical ( GMED ) said Thursday its board has authorized a share buyback program of up to $500 million. The timing and number of shares to be repurchased will be determined by the company's management and will depend on factors like market price of the shares, market conditions, and others, Globus said....

Amgen owes $406 million for monopolizing cholesterol drug market, US jury says

May 26, 2025

May 15 (Reuters) - A federal jury in Delaware said on Thursday that biotech company Amgen ( AMGN ) owes competitor Regeneron more than $406 million for engaging in anticompetitive behavior to increase sales of its cholesterol-reduction drug Repatha at the expense of Regeneron's rival drug Praluent. The jury agreed with Regeneron that Amgen ( AMGN ) unlawfully bundled Repatha...

Hapbee Teams Up with Liberty Alliance to Deliver Wearable Wellness Technology to the Defense Sector

May 26, 2025

04:55 PM EDT, 05/15/2025 (MT Newswires) -- Hapbee Technologies ( HAPBF ) after close of trade Thursday said it is teaming up with Liberty Alliance to introduce Hapbee's ( HAPBF ) proprietary ultra-low frequency wearable devices to military personnel, special operations forces, and veteran communities worldwide. The wellness technologies company said its wearable devices utilize patented ultra-low radiofrequency energy technology...